Carlos Campoy serves as Executive at CytomX Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Carlos Campoy has executed 6 insider transactions totaling $9.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 16, 2023 involved selling 1,748 shares valued at $3.5K.
Carlos Campoy currently holds 38,224 shares of CytomX Therapeutics, Inc. (CTMX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Carlos Campoy has been a net seller of CTMX stock. They have purchased $0 and sold $9.1K worth of shares.
Carlos Campoy's most recent insider trade was on Mar 16, 2023, when they sold 1,748 shares at $1.98 per share.
Get notified when new Form 4 filings are submitted
| $1.42 |
| Discretionary |
| Jul 19, 2022 | CTMX | $0 | Award | 15,000 | $N/A | Discretionary |
| Feb 2, 2022 | CTMX | $0 | Award | 22,500 | $N/A | Discretionary |
| May 31, 2021 | CTMX | $20.2K | Award | 3,320 | $6.09 | Discretionary |
| Nov 30, 2020 | CTMX | $19.8K | Award | 3,101 | $6.39 | Discretionary |